(Q35758294)

10 August 2017

title

Testosterone as a predictor of pathological stage in clinically localized prostate cancer (English)

1 reference

10 August 2017

1 reference

1 reference

1 reference

Hans Lilja

5

0 references

John P Mulhall

4

object named as

John P Mulhall

1 reference

10 August 2017

Ginger Isom-Batz

1

1 reference

10 August 2017

Fernando J Bianco

2

1 reference

10 August 2017

Michael W Kattan

3

1 reference

10 August 2017

James A Eastham

6

1 reference

10 August 2017

language of work or name

English

0 references

publication date

1 June 2005

1 reference

10 August 2017

1 reference

10 August 2017

volume

173

1 reference

10 August 2017

issue

6

1 reference

10 August 2017

page(s)

1935-1937

1 reference

The influence of finasteride on the development of prostate cancer

10 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1855287

Occult prostate cancer in men with low serum testosterone levels

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1855287

Prospective study of sex hormone levels and risk of prostate cancer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1855287

Independent prognostic factors in patients with metastatic (stage D2) prostate cancer. The Zoladex Study Group

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1855287

High levels of circulating testosterone are not associated with increased prostate cancer risk: a pooled prospective study

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1855287

The prevention of prostate cancer--the dilemma continues

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1855287

Pretreatment total testosterone level predicts pathological stage in patients with localized prostate cancer treated with radical prostatectomy

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1855287

Associations of serum testosterone with microvessel density, androgen receptor density and androgen receptor gene polymorphism in prostate cancer

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1855287

Pretreatment serum level of testosterone as a prognostic factor in Japanese men with hormonally treated stage D2 prostate cancer

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1855287

Neoadjuvant androgen ablation before radical prostatectomy in cT2bNxMo prostate cancer: 5-year results

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1855287

Relationships of serum androgens and estrogens to prostate cancer risk: results from a prospective study in Finland.

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1855287

Influence of radical prostatectomy on serum hormone levels

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1855287

Predicting the presence and side of extracapsular extension: a nomogram for staging prostate cancer

25 September 2018

1 reference

12 December 2020

Serum testosterone as a prognostic factor in patients with advanced prostatic carcinoma

1 reference

12 December 2020

Cell proliferation and apoptosis during prostatic tumor xenograft involution and regrowth after castration

1 reference

12 December 2020

Workgroup I: rodent models of prostate cancer

1 reference

12 December 2020

Low serum testosterone and a younger age predict for a poor outcome in metastatic prostate cancer

1 reference

12 December 2020

Serum testosterone--a significant determinant of metastatic relapse for irradiated localized prostate cancer

1 reference

12 December 2020

Is low serum free testosterone a marker for high grade prostate cancer?

1 reference

12 December 2020

On the prevention and therapy of prostate cancer by androgen administration

1 reference

12 December 2020

10.1097/01.JU.0000158040.33531.E7

Identifiers

DOI

1 reference

10 August 2017

1 reference

10 August 2017

1 reference